Acknowledgement
Supported by : National Natural Science Foundation of China (NSFC)
References
- Clemens CH, Samsom M, Van Berge Henegouwen GP, Smout AJ. Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome. Dig Dis Sci 2003;48:74-82. https://doi.org/10.1023/A:1021734414976
- Sanders KM. A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 1996;111:492-515. https://doi.org/10.1053/gast.1996.v111.pm8690216
- Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the world. J Neurogastroenterol Motil 2015;21:320-329. https://doi.org/10.5056/jnm14165
- Medland JE, Pohl CS, Edwards LL, et al. Early life adversity in piglets induces long-term upregulation of the enteric cholinergic nervous system and heightened, sex-specific secretomotor neuron responses. Neurogastroenterol Motil 2016;28:1317-1329. https://doi.org/10.1111/nmo.12828
- Okuda T, Haga T, Kanai Y, Endou H, Ishihara T, Katsura I. Identification and characterization of the high-affinity choline transporter. Nat Neurosci 2000;3:120-125. https://doi.org/10.1038/72059
- Okuda T, Haga T. Functional characterization of the human high-affinity choline transporter. FEBS Lett 2000;484:92-97. https://doi.org/10.1016/S0014-5793(00)02134-7
- Harrington AM, Lee M, Ong SY, et al. Immunoreactivity for highaffinity choline transporter colocalises with VAChT in human enteric nervous system. Cell Tissue Res 2010;341:33-48. https://doi.org/10.1007/s00441-010-0981-9
- Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci USA 2004;101:8762-8767. https://doi.org/10.1073/pnas.0401667101
- Takashina K, Bessho T, Mori R, Eguchi J, Saito K. MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats. J Neural Transm (Vienna) 2008;115:1027-1035. https://doi.org/10.1007/s00702-008-0048-1
-
Wang Z, Yang L, Zheng H. Role of app and
$A{\beta}$ in synaptic physiology. Curr Alzheimer Res 2012;9:217-226. https://doi.org/10.2174/156720512799361691 - Neumann SA, Linder KJ, Muldoon MF, et al. Polymorphic variation in choline transporter gene (CHT1) is associated with early, subclinical measures of carotid atherosclerosis in humans. Int J Cardiovasc Imaging 2012;28:243-250. https://doi.org/10.1007/s10554-011-9831-4
- English BA, Appalsamy M, Diedrich A, et al. Tachycardia, reduced vagal capacity, and age-dependent ventricular dysfunction arising from diminished expression of the presynaptic choline transporter. Am J Physiol Heart Circ Physiol 2010;299:H799-H810. https://doi.org/10.1152/ajpheart.00170.2010
- Penet MF, Shah T, Bharti S, et al. Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res 2015;21:386-395. https://doi.org/10.1158/1078-0432.CCR-14-0964
- Luo D, Chen L, Yu B. Inhibition of the high affinity choline transporter enhances hyperalgesia in a rat model of chronic pancreatitis. Biochem Biophys Res Commun 2017;488:204-210. https://doi.org/10.1016/j.bbrc.2017.05.036
- Tang D, Qian AH, Song DD, et al. Role of the potassium chloride cotransporter isoform 2-mediated spinal chloride homeostasis in a rat model of visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2015;308:G767-G778. https://doi.org/10.1152/ajpgi.00313.2014
- Qi D, Wu S, Zhang Y, Li W. Electroacupuncture analgesia with different frequencies is mediated via different opioid pathways in acute visceral hyperalgesia rats. Life Sci 2016;160:64-71. https://doi.org/10.1016/j.lfs.2016.06.025
- Gomez-Pinilla PJ, Gibbons SJ, Bardsley MR, et al. Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2009;296:G1370-G1381. https://doi.org/10.1152/ajpgi.00074.2009
- Mach T. The brain-gut axis in irritable bowel syndrome--clinical aspects. Med Sci Monit 2004;10:RA125-RA131.
- Zhou Q, Verne GN. New insights into visceral hypersensitivity--clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011;8:349-355. https://doi.org/10.1038/nrgastro.2011.83
- Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol 2017;312:G52-G62. https://doi.org/10.1152/ajpgi.00338.2016
- Gonzalez-Castro AM, Martinez C, Salvo-Romero E, et al. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome. J Gastroenterol Hepatol 2017;32:53-63.
- Hyland NP, Quigley EM, Brint E. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and braingut interactions. World J Gastroenterol 2014;20:8859-8866.
- Rojas-Macias V, Rodriguez-Fandino O, Jimenez-Ponce F, et al. [External validity of a relevant model for irritable bowel syndrome (IBS) using chronic stress by water avoidance in wistar rats.] Rev Gastroenterol Mex 2010;75:421-426.[Spanish]
- Lu H, Qian JM, Jin GL, Zhou DF, Shen YC. [The establishment of an animal model of gut-brain interaction in irritable bowel syndrome for the evaluation of visceral sensation, motility and psychological behavior.] Zhonghua Nei Ke Za Zhi 2009;48:1035-1039.[Chinese]
- Harrington AM, Hutson JM, Southwell BR. Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system. Prog Histochem Cytochem 2010;44:173-202. https://doi.org/10.1016/j.proghi.2009.10.001
- Murray K, Reardon C. The cholinergic anti-inflammatory pathway revisited. Neurogastroenterol Motil 2018;30.
- Golder M, Burleigh DE, Belai A, et al. Smooth muscle cholinergic denervation hypersensitivity in diverticular disease. Lancet 2003;361:1945-1951. https://doi.org/10.1016/S0140-6736(03)13583-0
- Caputi V, Marsilio I, Filpa V, et al. Antibiotic-induced dysbiosis of the microbiota impairs gut neuromuscular function in juvenile mice. Br J Pharmacol 2017;174:3623-3639. https://doi.org/10.1111/bph.13965
- Misawa H, Nakata K, Matsuura J, Nagao M, Okuda T, Haga T. Distribution of the high-affinity choline transporter in the central nervous system of the rat. Neuroscience 2001;105:87-98. https://doi.org/10.1016/S0306-4522(01)00147-6
- Yajima T, Inoue R, Matsumoto M, Yajima M. Non-neuronal release of ACh plays a key role in secretory response to luminal propionate in rat colon. J Physiol 2011;589(pt 4):953-962. https://doi.org/10.1113/jphysiol.2010.199976
- Li S, Fei G, Fang X, et al. Changes in enteric neurons of small intestine in a rat model of irritable bowel syndrome with diarrhea. J Neurogastroenterol Motil 2016;22:310-320. https://doi.org/10.5056/jnm15082
-
Zhu MH, Sung IK, Zheng H, et al. Muscarinic activation of
$Ca^{2+}$ -activated$Cl^-$ current in interstitial cells of Cajal. J Physiol 2011;589(Pt 18):4565-4582. https://doi.org/10.1113/jphysiol.2011.211094 - Bessho T, Takashina K, Tabata R, et al. Effect of the novel high affinity choline uptake enhancer 2 - (2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro[2, 3-b] quinolin-4-yl) acetoamide on deficits of water maze learning in rats. Arzneimittelforschung 1996;46:369-373.
- Murai S, Saito H, Abe E, Masuda Y, Odashima J, Itoh T. MKC-231, a choline uptake enhancer, lameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice. J Neural Transm Gen Sect 1994;98:1-13. https://doi.org/10.1007/BF01277590
- Takashina K, Bessho T, Mori R, Kawai K, Eguchi J, Saito K. MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake. J Neural Transm (Vienna) 2008;115:1037-1046. https://doi.org/10.1007/s00702-008-0049-0
- Shirayama Y, Yamamoto A, Nishimura T, Katayama S, Kawahara R. Subsequent exposure to the choline uptake enhancer MKC-231 antagonizes phencyclidine-induced behavioral deficits and reduction in septal cholinergic neurons in rats. Eur Neuropsychopharmacol 2007;17:616-626. https://doi.org/10.1016/j.euroneuro.2007.02.011
- Wang XM, Liu YL. [An investigation of signal transduction pathway of colonic mucosal toll-like receptor 4 in patients with diarrhea-irritable bowel syndrome.] Zhonghua Nei Ke Za Zhi 2010;49:491-494.[Chinese]
-
Khalid S, Ullah MZ, Khan AU, et al. Antihyperalgesic properties of honokiol in inflammatory pain models by targeting of NF-
${\kappa}B$ and Nrf2 signaling. Front Pharmacol 2018;9:140. https://doi.org/10.3389/fphar.2018.00140 - Jian-Min T, Jun L, Sheng-Yang C, et al. Tashinone II A-sulfoacid-natrum elevates the pain threshold through inhibiting nuclear factor kappa B pathway in neuropathic cancer pain. Indian J Cancer 2015;52(suppl 3):E179-E181.
-
Xia ZB, Yuan YJ, Zhang QH, Li H, Dai JL, Min JK. Salvianolic acid B suppresses inflammatory mediator levels by downregulating NF-
${\kappa}B$ in a rat model of rheumatoid arthritis. Med Sci Monit 2018;24:2524-2532. https://doi.org/10.12659/MSM.907084 - Porter AJ, Wattchow DA, Brookes SJ, Costa M. Cholinergic and nitrergic interneurones in the myenteric plexus of the human colon. Gut 2002;51:70-75. https://doi.org/10.1136/gut.51.1.70
- Burleigh DE. Ng-nitro-L-arginine reduces nonadrenergic, noncholinergic relaxations of human gut. Gastroenterology 1992;102:679-683. https://doi.org/10.1016/0016-5085(92)90120-N
- Crowell MD. The role of serotonin in the pathophysiology of irritable bowel syndrome. Am J Manag Care 2001;7(8 suppl):S252-S260.
- Forrest AS, Ordog T, Sanders KM. Neural regulation of slow-wave frequency in the murine gastric antrum. Am J Physiol Gastrointest Liver Physiol 2006;290:G486-G495. https://doi.org/10.1152/ajpgi.00349.2005
- Iwamoto H, Calcutt MW, Blakely RD. Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine. Neurochem Int 2016;98:138-145. https://doi.org/10.1016/j.neuint.2016.03.012
Cited by
- Intranasal Administration of Oxytocin Attenuates Stress Responses Following Chronic Complicated Stress in Rats vol.25, pp.4, 2018, https://doi.org/10.5056/jnm19065
- Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management vol.10, pp.15, 2018, https://doi.org/10.3390/jcm10153429